FGSRX
Price
$151.96
Change
+$0.23 (+0.15%)
Updated
Dec 3 closing price
Net Assets
18.18B
VIGRX
Price
$253.05
Change
+$0.01 (+0.00%)
Updated
Dec 3 closing price
Net Assets
357.2B
Interact to see
Advertisement

FGSRX vs VIGRX

Header iconFGSRX vs VIGRX Comparison
Open Charts FGSRX vs VIGRXBanner chart's image
Franklin Growth R
Price$151.96
Change+$0.23 (+0.15%)
VolumeN/A
Net Assets18.18B
Vanguard Growth Index Investor
Price$253.05
Change+$0.01 (+0.00%)
VolumeN/A
Net Assets357.2B
FGSRX vs VIGRX Comparison Chart in %
View a ticker or compare two or three
VS
FGSRX vs. VIGRX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FGSRX is a StrongBuy and VIGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 357B vs. FGSRX (18.2B). VIGRX pays higher dividends than FGSRX: VIGRX (0.30) vs FGSRX (0.00). FGSRX was incepted earlier than VIGRX: FGSRX (24 years) vs VIGRX (33 years). FGSRX (1.04) is less costly to investors than VIGRX (0.17). VIGRX is a more actively managed with annual turnover of: 11.00 vs. FGSRX (7.35). FGSRX has a lower initial minimum investment than VIGRX: FGSRX (1000) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 18.49 vs. FGSRX (2.57). VIGRX return over 5 years is better than : 99.11 vs. FGSRX (16.11).
FGSRXVIGRXFGSRX / VIGRX
Total Expense Ratio1.040.17612%
Annual Report Gross Expense Ratio1.040.17612%
Fund Existence24 years33 years-
Gain YTD15.61219.76479%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets18.2B357B5%
Annual Yield % from dividends0.000.30-
Returns for 1 year2.5718.4914%
Returns for 3 years28.26110.8225%
Returns for 5 years16.1199.1116%
Returns for 10 years103.55349.1330%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STOK30.961.15
+3.86%
Stoke Therapeutics
NEPH5.400.09
+1.69%
Nephros
TACO10.15N/A
N/A
Berto Acquisition Corp
HVIIU10.60N/A
N/A
Hennessy Capital Investmnt Corp VII
AHR50.31-0.13
-0.26%
American Healthcare REIT